Minimally differentiated acute myeloid leukemia: a morphologic, cytochemical and ultrastructural study. 1992

S S Alurkar, and H K Chopra, and C N Nair, and L V Zachariah, and Y Badrinath, and A Chougule, and S Dhond, and K A Kumar, and S A Barbhayh, and S H Advani
Department of Medical Oncology, Tata Memorial Hospital, Parel, Bombay, India.

Seven of 368 cases of acute myeloid leukemia (AML) could not be subclassified by routine morphologic, cytochemical and immunologic analyses during the period January 1989 to December 1990. Further investigations including ultrastructural examination, anti-myeloperoxidase and myeloid specific antigen analysis were carried out in all these patients and they were classified as AML-MO, as per the FAB criteria. Morphologically these blasts resembled ALL-L2/AML-M1. Cytochemically they were negative for Sudan black, myeloperoxidase, periodic acid-Schiff, and non-specific esterase. On initial immunophenotypic analysis, they could not be classified into B, T or myeloid lineages. Further investigations revealed CD13 and CD33 positivity in 4 of 6 patients. Anti-myeloperoxidase was positive in 6 of 6 patients and ultrastructural examination revealed myeloperoxidase-positive blasts in 6 of 7 cases. Cytogenetic analysis done in one patient revealed 60% abnormal metaphases. Six of 7 cases were treated with aggressive chemotherapy. One patient achieved complete remission but relapsed after 6 months, whereas others were resistant to treatment. Hence we conclude that an aggressive investigative and therapeutic approach is required to identify and treat AML-MO.

UI MeSH Term Description Entries
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D008297 Male Males
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell

Related Publications

S S Alurkar, and H K Chopra, and C N Nair, and L V Zachariah, and Y Badrinath, and A Chougule, and S Dhond, and K A Kumar, and S A Barbhayh, and S H Advani
September 1984, Medicina clinica,
S S Alurkar, and H K Chopra, and C N Nair, and L V Zachariah, and Y Badrinath, and A Chougule, and S Dhond, and K A Kumar, and S A Barbhayh, and S H Advani
January 1998, Ryoikibetsu shokogun shirizu,
S S Alurkar, and H K Chopra, and C N Nair, and L V Zachariah, and Y Badrinath, and A Chougule, and S Dhond, and K A Kumar, and S A Barbhayh, and S H Advani
January 1984, Acta haematologica,
S S Alurkar, and H K Chopra, and C N Nair, and L V Zachariah, and Y Badrinath, and A Chougule, and S Dhond, and K A Kumar, and S A Barbhayh, and S H Advani
August 1986, Blood,
S S Alurkar, and H K Chopra, and C N Nair, and L V Zachariah, and Y Badrinath, and A Chougule, and S Dhond, and K A Kumar, and S A Barbhayh, and S H Advani
June 1995, Gan to kagaku ryoho. Cancer & chemotherapy,
S S Alurkar, and H K Chopra, and C N Nair, and L V Zachariah, and Y Badrinath, and A Chougule, and S Dhond, and K A Kumar, and S A Barbhayh, and S H Advani
October 1988, American journal of clinical pathology,
S S Alurkar, and H K Chopra, and C N Nair, and L V Zachariah, and Y Badrinath, and A Chougule, and S Dhond, and K A Kumar, and S A Barbhayh, and S H Advani
January 1995, Leukemia & lymphoma,
S S Alurkar, and H K Chopra, and C N Nair, and L V Zachariah, and Y Badrinath, and A Chougule, and S Dhond, and K A Kumar, and S A Barbhayh, and S H Advani
September 1998, Leukemia & lymphoma,
S S Alurkar, and H K Chopra, and C N Nair, and L V Zachariah, and Y Badrinath, and A Chougule, and S Dhond, and K A Kumar, and S A Barbhayh, and S H Advani
March 1993, Leukemia research,
S S Alurkar, and H K Chopra, and C N Nair, and L V Zachariah, and Y Badrinath, and A Chougule, and S Dhond, and K A Kumar, and S A Barbhayh, and S H Advani
November 1999, Leukemia & lymphoma,
Copied contents to your clipboard!